<?xml version="1.0" encoding="UTF-8"?>
<p>A spectrum of neuropathological conditions has been reported in newborn babies exposed to ZIKV in uterus, being microcephaly the most severe outcome. Infants who develop ZIKV-induced microcephaly show recurrent seizures [
 <xref rid="B3-pharmaceuticals-12-00060" ref-type="bibr">3</xref>], and severely compromised neuropsychomotor development is frequently reported [
 <xref rid="B4-pharmaceuticals-12-00060" ref-type="bibr">4</xref>]. Several alterations were described after brain tomography of babies congenitally exposed to ZIKV, including widespread calcifications, cerebral atrophy, brainstem and cerebellar hypoplasia, as well as ventriculomegaly [
 <xref rid="B5-pharmaceuticals-12-00060" ref-type="bibr">5</xref>] (
 <xref ref-type="fig" rid="pharmaceuticals-12-00060-f001">Figure 1</xref>A). 
</p>
